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           The traffi   c of leucocytes into the central ner-
vous system (CNS) is a highly regulated pro-
cess. This protects the brain against the full 
ravages of the systemic infl  ammatory  re-
sponse that would otherwise compromise 
the delicate homeostasis required for neural 
activity. T cells, which initiate the adaptive 
immune response, traffi   c into the brain at a 
relatively low level compared with other or-
gans (  1  ). The question of whether antigen 
specifi  city is a prerequisite for T cell traffi   c 
into the brain has been previously addressed. 
Several investigators have transferred acti-
vated T cells reactive against neural or irrele-
vant antigens into naive animals and observed 
that both infi  ltrated the brain equally well 
(  2  –  7  ). However, all these studies concen-
trated on CD4 T cells; although CD8 T cells 
were present among the transferred cells in some 
experiments (  3, 4  ), no attempt was made to 
elucidate whether the antigen specifi  city of the 
CD8 T cells was infl  uencing their infi  ltration 
into the brain. 
  There is reason to suspect that traffi   c of 
CD8 T cells recognizing antigens within the 
brain is favored over that of irrelevant CD8 
T cells. In mice immunized with the myelin 
oligodendrocyte glycoprotein peptide MOG 
35  –  55 that develop experimental autoimmune 
encephalomyelitis, 56% of brain-infi  ltrating 
CD8 T cells on day 10 were MOG specifi  c (  8  ). 
In humans with multiple sclerosis (MS), oligo-
clonal dominance of T cells in cerebrospinal 
fl  uid (CSF) (  9  ) and brain parenchyma (  10  ) are 
seen more commonly with CD8 than CD4 
T cells. Although this has been interpreted as 
oligoclonal expansion within the CNS com-
partment, antigen-specifi  c CD8 T cell infi  ltra-
tion could also contribute because the CD8 
T cell clones were present in blood. 
  CD8 T cells are instrumental in the body  ’  s 
response to viral encephalitides and tumors. 
However, they are also responsible for various 
infl  ammatory neurological conditions such as 
MS, human T cell lymphotropic virus  –  associated 
myelopathy, and a whole host of neurological 
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  CD8 T cells are nature  ’  s foremost defense in encephalitis and brain tumors. Antigen-
  specifi  c CD8 T cells need to enter the brain to exert their benefi  cial effects. On the other 
hand, traffi  c of CD8 T cells specifi  c for neural antigen may trigger autoimmune diseases 
like multiple sclerosis. T cell traffi  c into the central nervous system is thought to occur 
when activated T cells cross the blood-brain barrier (BBB) regardless of their antigen 
specifi  city, but studies have focused on CD4 T cells. Here, we show that selective traffi  c 
of antigen-specifi  c CD8 T cells into the brain occurs in vivo and is dependent on luminal 
expression of major histocompatibility complex (MHC) class I by cerebral endothelium. 
After intracerebral antigen injection, using a minimally invasive technique, transgenic CD8 
T cells only infi  ltrated the brain when and where their cognate antigen was present. This 
was independent of antigen presentation by perivascular macrophages. Marked reduction 
of antigen-specifi  c CD8 T cell infi  ltration was observed after intravenous injection of 
blocking anti     MHC class I antibody. These results expose a hitherto unappreciated route 
by which CD8 T cells home onto their cognate antigen behind the BBB: luminal MHC class I 
antigen presentation by cerebral endothelium to circulating CD8 T cells. This has implica-
tions for a variety of diseases in which antigen-specifi  c CD8 T cell traffi  c into the brain is 
a benefi  cial or deleterious feature. 2024 ANTIGEN-SPECIFIC CD8 T CELL TRAFFIC ACROSS THE BBB | Galea et al.
occurred when the cognate antigen was present within the 
brain parenchyma. This proves that a mechanism capable of 
favoring antigen-specifi  c CD8 T cell infi  ltration exists. To 
elucidate the origin of this antigen specifi  city, we depleted 
the brain of perivascular macrophages (PVMs), which are 
considered to be the foremost antigen-presenting cells at the 
blood-brain barrier (BBB), but this had no eff  ect on CD8 
T cell infi  ltration. We show that MHC class I expression by 
cerebral endothelium was luminal and, when blocked, resulted 
in a marked reduction of CD8 T cell infi  ltration. 
    RESULTS AND DISCUSSION   
  Antigen-specifi  c CD8 T cell traffi  c into the brain 
  In CL4 mice, CD8 T cells exhibit high avidity for the HA512-
520 peptide (HA), which is K  d   restricted (  16  ). To investigate 
CD8 T cell traffi   c, we injected antigen dissolved in sterile PBS 
into the right striatum of CL4 mice. A small volume (0.5      L) 
was delivered with a sterile, fi  nely drawn glass micropipette, 
the tip of which measured 2  –  10      m in diameter, to minimize 
tissue trauma and refl  ux into the periphery. Mice were killed 
paraneoplastic syndromes (  11  ). The crucial role of CD8 
T cells in MS has only recently been recognized. It has been 
shown that CD8 T cells specifi  c for myelin antigen can initi-
ate severe experimental autoimmune encephalomyelitis dis-
ease when adoptively transferred (  12  ). However, CD8 T cells 
are also important in disease maintenance because their num-
ber correlated with axon injury in MS plaques (  13  ) and mag-
netic resonance imaging features of tissue destruction (  14  ). 
CD8 T cell  –  mediated neuropathology may be mediated di-
rectly by CNS antigen-specifi  c CD8 T cells or may occur in-
directly as a result of bystander damage by co-infi  ltrating CD8 
T cells with irrelevant antigen specifi  cities. However, the 
overall contribution of bystander damage has been shown to 
be small (  15  ). The factors governing antigen-specifi  c infi  ltra-
tion of CD8 T cells into the brain are therefore important in 
both disease induction and maintenance. 
  To study antigen-specifi   c CD8 T cell traffi   c  into  the 
brain, we injected antigen into the striatum of CL4 trans-
genic mice in which  95% of CD8 T cells express the V     10 
V     8.2 TCR (  16  ). We show that CD8 T cell infi  ltration only 
  Figure 1.     An antigen-specifi  c model of CD8 T cell infi  ltration into the brain. (A and B) CD8 T cell recruitment 3 d after HA (A) or control Cw3 
(B) peptide intrastriatal injection. (C) Kinetics of CD8 T cell recruitment after HA injection. (D H) CD8 T cell infi  ltration 3 d after 3 million (D G) or 30 
million (H) in vitro activated CL4 Thy1.1      CD8 T cells were injected i.v. in Thy1.2-congenic wild-type BALB/c mice at the time of right intrastriatal HA (D F) 
or Cw3 (G and H) injection. D F show confocal micrographs of CD8 (red, E) and Thy1.1 (green, D) immunofl  uorescence, merged in F. G and H are light 
micrographs after CD8 immunohistochemistry (brown). (I P) CD8 immunohistochemistry (brown) of striatum in CL4 mice after simultaneous HA and 
Cw3 injection in right (I and K) and left (J and L) striatum, on days 3 (I and J) and 1 (K and L); irrelevant adenovirus injection, days 1 (M) and 3 (N); stab 
lesion, days 1 (O) and 3 (P). Q is a representative merged confocal micrograph after double immunofl  uorescence of striatum for CD8 (red) and Ki67 
(green) on day 1 after HA injection in CL4 mice. Bars: A and B, D H, and Q, 50     m;  I – L,  30      m; M  –  P, 20     m.   JEM VOL. 204, September 3, 2007  2025
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expected to see CD8 T cells in the Cw3-injected hemisphere. 
However, CD8 T cells only infi  ltrated the HA-injected hemi-
sphere; none were present in the contralateral hemisphere 
(  Fig. 1, I and J  ). 
  The above experiments showed that the transgenic CD8 
T cells were recruited only to the site where cognate antigen 
was present in the brain parenchyma. It is currently thought 
that a basal low level of immunosurveillance by T cells oc-
curs in the brain (  18  ). Therefore, the CD8 T cells could, as 
part of normal surveillance, have infi  ltrated the parenchyma in 
a non-antigen  –  specifi  c fashion only to be retained or to pro-
liferate if their cognate antigen was present (antigen-specifi  c 
retention and/or proliferation, respectively). We therefore 
asked whether CD8 T cells recruited into the brain in a non-
antigen  –  specifi  c fashion persist for any length of time in the 
absence of their cognate antigen. In separate experiments, 
CL4 mice received an injection of an irrelevant adenovirus 
(Ad70-3) or a sterile stab lesion in the right striatum (  n     3 
each time point). Both manipulations recruited CD8 T cells, 
which were seen at day 1 and persisted until day 3 (  Fig. 1, 
M  –  P  ). This means that had CD8 T cells been recruited in a 
non-antigen  –  specifi  c fashion after Cw3 injection, they would 
have been seen on days 1 or 3. To further test this hypothe-
sis, CL4 mice injected with HA in one hemisphere and Cw3 
in the contralateral hemisphere (  n     3) were perfused at an 
earlier time point (day 1 after injection) to see whether T 
cells were failing to persist until day 3 after injection in the 
contralateral hemisphere. No CD8 T cells were seen in the 
Cw3-injected hemisphere (  Fig. 1 L  ), but CD8 T cells were 
observed in the HA-injected side, with some in a perivascu-
lar location representing the initial phase of CD8 T cell 
migration (  Fig. 1 K  ). Confocal microscopy showed that CD8 
T cells infi  ltrating the striatum on day 1 after cognate antigen 
injection did not express the nuclear proliferation marker 
Ki67 and therefore were not proliferating (  Fig. 1 Q  ). There-
fore, initial CD8 T cell accumulation within the parenchyma 
was the result of antigen-specifi  c infi  ltration rather than non-
antigen  –  specifi  c infi  ltration followed by antigen-specifi  c re-
tention or proliferation. 
  The role of cerebral PVMs 
  We next addressed whether antigen presentation at the BBB 
is a potential mechanism whereby CD8 T cells specifi  cally 
on days 1, 3, 5, and 7 after injection (minimum   n     3 per time 
point). Because virtually all CD8 T cells in this mouse express 
the transgenic TCR, we used CD8 immunohistochemistry to 
track antigen-specifi  c CD8 T cells in the brain parenchyma. 
Serial section immunohistochemistry had shown that all CD8  
cells were CD  (unpublished data). 
  Intrastriatal injection of HA resulted in a focal CD8 T cell 
infi  ltrate, which was strictly limited to the area of antigen 
deposition (    7.5 mm  2  ) as shown by a co-injected inert blue 
dye (  Fig. 1 A  ).   This T cell infi  ltrate peaked at day 3, reaching 
a density of 88 cells/mm  2  , and had nearly disappeared by 
day 7 (  Fig. 1 C  ). No CD8 T cells were seen in the contralateral 
hemisphere. Moreover, CD8 T cell infi  ltration did not occur 
at any time point after control intrastriatal injections of a K  d  -
restricted noncognate antigen, Cw3 peptide (  Fig. 1 B  ). This 
showed that CD8 T cells were accumulating at the site of 
injection as a result of the presence of antigen. 
  The CD8 T cell infi  ltrate observed was not a peculiarity 
of the CL4 transgenic mouse. Using a diff  erent approach 
in a nontransgenic animal, we transferred 3 million in vitro  –
  activated CL4 Thy1.1  CD8 T cells into Th1.2-congenic wild-
type BALB/c recipients at the time of intrastriatal HA injection 
(  n     3) and perfused them after 3 d. As expected, CD8 T cells 
were observed in the right striatum of HA-injected animals. 
The vast majority of parenchymal CD8 T cells ( 95%) were 
Thy1.1      (  Fig. 1, D  –  F  ), indicating that they were donor HA-
specifi  c CD8 T cells. No T cells were seen infi  ltrating the 
brains of wild-type BALB/c mice receiving Cw3 in the right 
striatum and 3 or 30 million in vitro  –  activated CL4 CD8 
T cells i.v. (  n     3 each dose) (  Fig. 1, G and H  ). 
  The marked diff  erence in CD8 T cell accumulation be-
tween the HA and Cw3 injections in the striatum of CL4 
mice suggested that CD8 T cells were sensitive to the local 
presence of their cognate antigen in the CNS. HA is a solu-
ble peptide and is likely to   “  leak  ”   to the periphery (  17  ). One 
possibility was that CD8 T cells were migrating into the stri-
atum in a non-antigen  –  specifi  c way at the site of intracere-
bral injection after being activated in the periphery by the 
leaking HA. To investigate this possibility, we injected HA 
into one hemisphere and Cw3 into the contralateral hemi-
sphere of CL4 mice and killed them on day 3 after injection 
(  n     3). If peripherally activated transgenic T cells were mi-
grating nonspecifi  cally to the site of injection, we would have 
  Figure 2.     Cerebral PVM depletion does not affect antigen-specifi  c CD8 T cell infi  ltration into the brain. (A and B) Mannose receptor immuno-
histochemistry (brown) of striatum after clodronate (A) and control (B) liposome intracerebroventricular infusion in CL4 mice. Bar, 50      m. (C) Quantifi  cation of 
CD8 T cell infi  ltration 3 d after intrastriatal HA injection in CL4 mice pretreated with clodronate or control liposomes (two-tailed Student  ’ s   t   test,  P     0.767).   2026 ANTIGEN-SPECIFIC CD8 T CELL TRAFFIC ACROSS THE BBB | Galea et al.
an intrastriatal injection of cognate antigen, and they were per-
fused 3 d later. Similar numbers of CD8 T cells had infi  ltrated 
the parenchyma in both the PVM-depleted and control groups 
(  Fig. 2 C  ), indicating that antigen presentation by PVMs was 
not directing CD8 T cell traffi   c into the brain. 
  The role of cerebral endothelium 
  Because an antigen-presenting process was suspected to play 
an important role in CD8 T cell infi  ltration, we studied the 
expression of MHC class I by immunohistochemistry on days 
0, 0.5, 1, 1.5, 2, 2.5, 3, 5, and 7 after intrastriatal injection of 
HA in CL4 mice (at least   n     3 for each time point). In naive 
uninjected animals, a very low basal level of MHC class I ex-
pression by endothelium was noted (  Fig. 3 A  ).   Constitutive 
home in on their target behind the BBB. Cerebral PVMs are 
strategically located at the BBB between the endothelial base-
ment membrane and the glia limitans, and are considered to 
be the brain  ’  s foremost antigen-presenting cells (  19  ). We there-
fore investigated whether PVMs play a role in antigen-specifi  c 
CD8 T cell traffi   c. CL4 mice were depleted of cerebral PVMs 
with an intracerebroventricular infusion of clodronate-loaded 
liposomes as described previously (  20  ) (  n     6) (  Fig. 2 A  ).   These 
liposomes are selectively phagocytosed by cerebral PVMs, 
leading to progressive intracellular accumulation of sodium 
clodronate. This kills all PVMs by day 5 as a result of adenosine 
triphosphate depletion and apoptosis (  20  ). Control CL4 mice 
(  n     4) received an intracerebroventricular infusion of empty 
liposomes (  Fig. 2 B  ). On day 5, both groups of mice received 
  Figure 3.     The role of endothelial MHC class I in antigen-specifi  c CD8 T cell infi  ltration into the brain. (A F) Immunohistochemistry (brown) 
for MHC class I (A E) and CD8 (F) in naive striatum (A) and striatum from CL4 mice injected with Cw3 (B) or HA (C F). E and F show serial sections. 
(G I) Immunohistochemistry (brown) for biotinylated IgG 3 d after intrastriatal HA injection (day 0) in CL4 mice receiving i.v. biotinylated anti MHC 
class I antibody (H and I) or control biotinylated IgG (G) on day 2. (J) CL4 mice injected with HA intrastriatally received an i.v. bolus of blocking anti MHC 
class I antibody or control IgG on day 2 and were perfused on day 3. There was a 76% reduction (95% CI       139.5  to   40.0) in CD8 T cell infi  ltration 
(two-tailed  Student ’ s   t   test,  P    0.002). (K M) High power confocal micrographs after double immunofl  uorescence on striatum for biotin (green in K) 
and      1-laminin (red in L) (merged in M) 3 d after intrastriatal HA injection (day 0) in CL4 mice receiving i.v. biotinylated anti MHC class I antibody on 
day 2. Bars: K M, 10      m; E and F, 30     m;  A    C, 50      m; G and H, 100      m; D and I, 200     m.   JEM VOL. 204, September 3, 2007  2027
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anti-K  d   blocking antibody (  n     6) or control IgG (  n     6) in 
200      L of sterile PBS on day 2, 1 d before peak CD8 T cell 
recruitment. Blocking of luminal MHC class I resulted in a 
76% reduction in CD8 T cell recruitment (  Fig. 3 J  ), indicat-
ing that circulating CD8 T cells use luminal endothelial MHC 
class I as a molecular address to target their cognate antigen 
within the brain parenchyma. The critical interaction be-
tween circulating CD8 T cells and MHC I occurred on the 
luminal aspect of the endothelium because confocal micros-
copy showed that i.v. injected biotinylated anti-K  d   blocking 
antibody binding was limited to the luminal aspect of the 
endothelium (  Fig. 3, K  –  M  ). 
  CD8 T cells infi  ltrating the brain after intrastriatal injec-
tions of HA in CL4 mice were not fully diff  erentiated at any 
time point, as shown by the lack of granzyme B expression 
(  Fig. 4 A  ) and lack of tissue damage, as assessed by amyloid 
precursor protein expression to detect damaged axons (  Fig. 4 B  ) 
and Luxol Fast Blue histochemistry to detect myelin damage 
(  Fig. 4 C  ).   In contrast, granzyme B expression and axon/
myelin damage were seen when CD8 T cells were peripherally 
activated by immunization with HA in CFA (  Fig. 4, D  –  F  ) or 
after in vitro activation (  Fig. 4, G  –  I  ). CD8 T cells infi  ltrat-
ing the brain after HA injection alone did not proliferate on 
day 1 (  Fig. 1 Q  ) but started expressing Ki67 at later time 
points (  Fig. 5, A and B  ). Expression of Ki67 is an indicator of 
commitment to the cell cycle, and the Ki67 index is the per-
centage of CD8 T cells expressing this marker; the Ki67 in-
dex was 21% on day 2 and peaked at 52% on day 3. 
  Therefore, the number of CD8 T cells within the brain 
parenchyma at time points beyond day 1 can be considered 
MHC class I expression was slightly up-regulated upon injec-
tion of Cw3 (  Fig. 3 B  ). After injection of HA, there was dra-
matic up-regulation of MHC class I by endothelial cells, 
peaking at day 3 (  Fig. 3 C  ). This up-regulation was largely 
limited to the site of antigen deposition (  Fig. 3 D  ) and coin-
ciding temporally and spatially with peak CD8 T cell infi  ltra-
tion. CD8 T cells were seen in association with MHC class 
I      blood vessels at various stages of infi  ltration (  Fig. 3, E and F  ). 
This raised the possibility that CD8 T cell traffi   c into the 
brain was facilitated by recognition of the cognate antigen 
presented by cerebral endothelial cells. For this to occur, 
however, antigen presentation by cerebral endothelial MHC 
class I would have to be luminal. 
  To investigate whether the up-regulated endothelial MHC 
class I was luminally expressed, CL4 mice received an intra-
cerebral injection of HA peptide followed 3 d later by an i.v. 
injection of 200      g of biotinylated anti-K  d   antibody (  n     3) or 
biotinylated control IgG (  n     3) in 200      L of sterile PBS. 
Mice were perfused 3 h later, and the biotinylated antibody 
was detected on tissue sections. Luminal expression of MHC 
class I was observed in the striatum and was restricted to the 
site of CD8 T cell infi  ltration in animals receiving biotinylated 
anti-K  d   (  Fig. 3, H and I  ); it was below the limit of detection 
in the contralateral hemisphere. BBB breakdown was ex-
cluded by the lack of staining in sections from mice receiving 
the biotinylated control IgG (  Fig. 3 G  ). 
  To directly address the issue of whether luminal endothe-
lial MHC class I was responsible for antigen-specifi  c CD8 
T cell migration, CL4 mice received an intrastriatal injection 
of HA peptide on day 0, followed by an i.v. injection of 200      g 
  Figure 4.     Brain-infi  ltrating CD8 T cells were not fully activated in this model of antigen-specifi  c CD8 T cell traffi  c. (A – I)  Representative 
sections 3 d after intrastriatal injection of HA in CL4 mice immunized intradermally with CFA alone (A  –  C) or HA in CFA (D  –  F) 5 d previously, and in wild-type 
littermates receiving 3 million in vitro     activated CL4 CD8 T cells i.v. (G I). Sections were submitted to immunohistochemistry (brown) for granzyme B 
(A, D, and G), amyloid precursor protein (B, E, and H), or Luxol Fast Blue histochemistry (C, F, and I). Bars are 60      m except for the following: A, 30     m; 
D, 20      m; G, 10     m.   2028 ANTIGEN-SPECIFIC CD8 T CELL TRAFFIC ACROSS THE BBB | Galea et al.
intercellular adhesion molecule (ICAM)-1, and the strength of 
this interaction is potentiated by chemokine receptor signaling. 
Arrest of T cell rolling suggesting adhesion, similar to that 
seen with chemokine ligand  –  chemokine receptor binding, 
has been observed after cognate MHC-TCR interaction (  23  ). 
Also, MHC-peptide  –  TCR interaction gives rise to a similar 
increase in avidity of LFA-1 to ICAM-1 (  24  ) as happens after 
chemokine receptor ligation. The affi   nity of a typical MHCI-
peptide  –  TCR interaction is less than that of LFA-1  –  ICAM-1 
(K  D   of 10      M [  25  ] and 500 nM [  26  ], respectively), but it is 
strengthened by the accompanying MHCI  –  CD8 interaction. 
Moreover, cognate MHCI-peptide  –  TCR interaction results 
in the formation of a supramolecular activation cluster that re-
cruits LFA-1, thereby strengthening overall adhesion. 
  An integral requirement of MHC-dependent CD8 T cell 
traffi   c into the brain is the presentation of processed exoge-
nous antigen by MHC class I on the luminal surface of cere-
bral endothelium. Interestingly, presentation of endogenous 
antigen by endothelial cells in peritoneum and cremasteric 
venules facilitates diapedesis of T cells (  27  ). We used HA 
peptide in our experiments to simulate the availability of pro-
cessed antigen within the extracellular milieu of brain paren-
chyma under infl  ammatory conditions. Various CNS proteins 
are released into the CSF in the course of neuropathology 
that may be degraded into smaller proteins or peptides by in-
terstitial enzymes. Cross-presentation by endothelial cells has 
been reported to occur in the pancreas (  28  ). It remains to be 
shown in brain endothelium. 
  In this study, we used an antigen-naive system. CL4 mice 
were housed in individually fi  ltered cages throughout and 
were not allowed to come into contact with sources of infl  u-
enza infection. HA was stereotaxically injected into the stria-
tum using very fi  ne glass micropipettes; great care was taken 
to avoid refl  ux to the periphery and minimize trauma to sur-
rounding tissue. Indeed brain-infi  ltrating CD8 T cells were 
not activated on day 1 after such injections in CL4 mice. In 
agreement with a recent study (  29  ), our results suggest that 
activation is not an absolute prerequisite for CNS infi  ltration 
by CD8 T cells. CD8 T cells entered the cell cycle after infi  l-
trating the brain, but there was no detectable granzyme B ex-
pression or tissue damage at any time point, indicating that 
they were not fully activated to achieve cytotoxic potential. 
to be a result of two processes: infi  ltration and proliferation. 
This raised the question of whether the i.v. injected blocking 
anti-K  d   antibody, which resulted in a 76% reduction in pa-
renchymal CD8 T cell numbers after cognate antigen injec-
tion in the striatum, could have aff  ected proliferation rather 
than infi  ltration. To address this issue, we studied the CD8 
T cell Ki67 index in CL4 mice receiving HA in the striatum, 
followed by blocking anti-K  d   antibody or control isotype 
i.v. 2 d later. No diff  erence in Ki67 index was observed 
(  Fig. 5 C  ).   This provides defi  nitive evidence that the blocking 
anti-K  d   antibody acted by inhibiting infi  ltration rather than 
proliferation of CD8 T cells in the brain. 
  Antigen-specifi  c CD8 T cell traffi  c: concluding remarks 
  The study of T cell traffi   c into the brain has been dominated 
by CD4 T cells in view of their perceived importance in 
neuroinfl  ammatory disease. This is now changing, and CD8 
T cells are increasingly recognized as major players (  11  ), but 
relatively little is known about CD8 T cell traffi   c into the 
brain. Here, we show that unlike CD4 T cells, antigen speci-
fi  city is a factor that governs CD8 T cell infi  ltration into the 
brain. We also demonstrate that the underlying mechanism 
favoring antigen-specifi  c CD8 T cell traffi   c is luminal expres-
sion of MHC class I by cerebral endothelium, which acts as 
a molecular address at the BBB. This crucial diff  erence be-
tween CD4 and CD8 T cell traffi   c into the brain is a refl  ec-
tion of cerebral endothelial cell biology. Low level MHC 
class I, but not class II, expression by cerebral endothelium 
occurs constitutively (  21  ). Therefore, the mechanism for ini-
tiating transendothelial antigen-specifi  c T cell traffi   c into the 
naive brain only exists for CD8 T cells. This situation might 
have evolved as a result of selective pressure in favor of en-
hanced antiviral immunosurveillance of the CNS (  18  ). 
  The additional molecular requirements for the MHC-
dependent transendothelial T cell migration we describe here 
are known to be present at the cerebral endothelium. As else-
where in the body, T cell infi  ltration into the brain is a three-
step process: rolling, adhesion, and diapedesis (  22  ). Strong 
adhesion is a requirement for subsequent diapedesis, and this 
was classically thought to be mediated by interaction between 
integrins on the T cell surface and cellular adhesion molecules 
on the endothelium. An example of such a pair is LFA-1 and 
  Figure 5.     Intravenously administered anti MHC class I antibody does not affect proliferation of brain-infi  ltrating CD8 T cells in this model 
of antigen-specifi  c CD8 T cell traffi  c. (A) Merged confocal micrograph after double immunofl  uorescence for CD8 (red) and Ki67 (green) on striatum 
from CL4 mice 3 d after HA injection. (B) Ki67 index of brain-infi  ltrating CD8 T cells at several time points after intrastriatal HA injection in CL4 mice. 
(C) Ki67 index of brain-infi  ltrating CD8 T cells 3 d after intrastriatal HA injection (day 0) in CL4 mice receiving i.v. blocking anti MHC class I antibody or 
control IgG on day 2 (two-tailed Student  ’  s   t   test,  P    0.844). Bar, 20     m.   JEM VOL. 204, September 3, 2007  2029
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  Cell culture.     CL4 CD8 T cells were purifi  ed by positive selection as de-
scribed previously (  18  ). 
  Immunization.     CL4 mice were immunized with an intradermal injection 
of 100      L PBS/CFA (1:1) with or without 5      g HA. On day 5, the animals 
received an intrastriatal injection of HA followed by perfusion 5 d later. 
  Adoptive transfer.     Wild-type BALB/c mice received an intrastriatal injec-
tion of HA or Cw3, and 4 h later they were injected i.v. with 3 or 30 million 
in vitro  –  activated CL4 CD8 T cells in 200      L DMEM. They were perfused 
3 d later. 
  Quantifi  cation.     This was performed manually under light or fl  uorescence 
microscopy. The operator was blinded to the identity of the slides counted. 
Cells were counted using a graticule under a high power objective (     25), and 
the density of cells was converted to a value per mm  2  . In all cases, at least four 
lesion-center sections (as shown by the co-injected blue dye) from the same 
animal and several animals from each experimental group (as denoted by 
number   n  ) were taken, and counts were averaged. 
  Statistics.     Data were analyzed using SPSS version 12. All the data were 
parametric, and therefore the two-tailed Student  ’  s   t   test for two independent 
samples was used throughout. The confi  dence level was 95%. 
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